Evidence map›Paper›PMID 24719447›Full record

ArticleJournal of clinical microbiology2014

Comparison of tetrazolium salt assays for evaluation of drug activity against Leishmania spp.

Marine Ginouves, Bernard Carme, Pierre Couppie, Ghislaine Prevot

Open access · bronzeAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Interaction of apigenin-7-O-glucoside with pyrimethamine againstJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2020
    Article
  8. Article
  9. Activity and Effectiveness of Recombinant hEGF Excreted byJournal of experimental pharmacology · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. In Vitro Sensitivity of CutaneousThe American journal of tropical medicine and hygiene · 2017
    Article
  15. A Critical Analysis of the AvailableJournal of ophthalmology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Marine GinouvesUniversité des Antilles et de la Guyane, Laboratoire d'Épidémiologie des Parasitoses Tropicales EA 3593, Labex CEBA UFR de Médecine, Cayenne, French Guiana.
Bernard CarmeUniversité des Antilles et de la Guyane, Laboratoire d'Épidémiologie des Parasitoses Tropicales EA 3593, Labex CEBA UFR de Médecine, Cayenne, French Guiana Laboratoire Hospitalo-Universitaire de Parasitologie et Mycologie, Centre Hospitalier de Cayenne, Cayenne, French Guiana.
Pierre CouppieUniversité des Antilles et de la Guyane, Laboratoire d'Épidémiologie des Parasitoses Tropicales EA 3593, Labex CEBA UFR de Médecine, Cayenne, French Guiana Service de Dermatologie, Centre Hospitalier de Cayenne, Cayenne, French Guiana.
Ghislaine PrevotUniversité des Antilles et de la Guyane, Laboratoire d'Épidémiologie des Parasitoses Tropicales EA 3593, Labex CEBA UFR de Médecine, Cayenne, French Guiana fac.prevot@gmail.com.
University of French Guiana · GFCentre Hospitalier Andrée Rosemon · GF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In French Guiana, leishmaniasis is an essentially cutaneous infection. It constitutes a major public health problem, with a real incidence of 0.2 to 0.3%. Leishmania guyanensis is the causal species most frequently encountered in French Guiana. The treatment of leishmaniasis is essentially drug based, but the therapeutic compounds available have major side effects (e.g., liver damage and diabetes) and must be administered parenterally or are costly. The efficacy of some of these agents has declined due to the emergence of resistance in certain strains of Leishmania. There is currently no vaccine against leishmaniasis, and it is therefore both necessary and urgent to identify new compounds effective against Leishmania. The search for new drugs requires effective tests for evaluations of the leishmanicidal activity of a particular molecule or extract. Microculture tetrazolium assays (MTAs) are colorimetric tests based on the use of tetrazolium salts. We compared the efficacies of three tetrazolium salts-3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT), and 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium (WST-8)-for quantification of the promastigotes of various species of Leishmania. We found that the capacity of Leishmania to metabolize a tetrazolium salt depended on the salt used and the species of Leishmania. WST-8 was the tetrazolium salt best metabolized by L. guyanensis and gave the best sensitivity.

Indexed as

Antiprotozoal AgentsColorimetryFrench GuianaHumansLeishmaniaParasitic Sensitivity TestsSensitivity and SpecificityTetrazolium SaltsAntiprotozoal AgentsTetrazolium Salts

Identifiers

PMID24719447
PMCPMC4042777
OpenAlexW2042001562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.